http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-1381959-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_96f271da93cd6b6d31f0eda6f68d1aa2
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D217-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D271-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K-
filingDate 1972-04-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1975-01-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber GB-1381959-A
titleOfInvention 1,2,3,4-tetrahydroisoquinolines and the process for their preparation
abstract 1381959 Derivatives of 3-phenyl-1,2,4-oxadiazole POLI INDUSTRIA CHIMICA SpA 21 April 1972 [22 April 1971] 18601/72 Heading C2C The invention comprises compounds of formula and their non-toxic acid addition salts, wherein R is H or MeO, R<SP>1</SP> is H, Me, Et or Pr, and R<SP>11</SP> is H or Me, and a process for preparing them by reacting PhC(NH 2 )ÀNOCOCH 2 CH 2 Cl with the appropriate N-unsubstituted tetrahydroisoquinoline. Therapeutic compositions, preferably administered orally, comprise compounds of the above formula, which have anti-cough, analgesic, antiinflammatory, antiseptic and local anaesthetic activity.
priorityDate 1971-04-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456485498
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422143614
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12260139
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425386533
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7046

Total number of triples: 19.